名稱 | GLP1R/CRE-Luc/BHK GPCR細(xì)胞 |
型號(hào) | CBP71405 |
報(bào)價(jià) | |
特點(diǎn) | GLP1R/CRE-Luc/BHK |
產(chǎn)品搜索
相關(guān)文章
- 耐藥ATCC細(xì)胞株如何構(gòu)建看完就會(huì)知道
- 【新品上線】多重病原菌質(zhì)控品
- 【盤點(diǎn)】癌癥免疫檢查點(diǎn)療法的現(xiàn)狀與展望
- 偏頭痛治療靶點(diǎn)——CGRP與藥篩細(xì)胞模型
- ATCC細(xì)胞如何培養(yǎng)?
- 細(xì)胞株定期維護(hù)與監(jiān)測(cè)要做好哪些?
- 【產(chǎn)品推介】VEGFR-2(KDR)小分子抑制劑細(xì)胞篩選模型
- 肥胖與腫瘤治療新星靶點(diǎn)——GDF15-GFRAL
- CYP2D6基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- MicroRNA或可特異性地殺死攜帶常見突變的癌細(xì)胞
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > GPCR細(xì)胞株 > CBP71405GLP1R/CRE-Luc/BHK GPCR細(xì)胞
- 詳細(xì)內(nèi)容
CBP71405 | |
I. Background | |
GLP1R binds specifically the glucagon-like peptide-1 (GLP1) and has much lower affinity for related peptides such as the gastric inhibitory polypeptide and glucagon. GLP1R is known to be expressed in pancreatic beta cells. Activated GLP1R stimulates the adenylyl cyclase pathway which results in increased insulin synthesis and release of insulin. Consequently, GLP1R has been suggested as a potential target for the treatment of diabetes. GLP1R is also expressed in the brain where it is involved in the control of appetite. Furthermore, mice which over express GLP1R display improved memory and learning. | |
II. Introduction | |
Host Cell: | BHK |
Stability: | 20 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Synonym(s): | GLP1R |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | MEM+10% FBS+1% Non Essential Amino Acids (NEAA)+1 mM sodium pyruvate+2ug/ml puromycin+800ug/ml hygromycin |
Mycoplasma Status: | Negative |
Storage: | Liquid nitrogen immediately upon delivery |
Application(s): | Functional assay for GLP1R receptor |
Transducer: | Gs |
Ⅲ. Description of Host Cell Line | |
Organism: | Mesocricetus auratus, hamster, Syrian golden |
Tissue: | kidney |
Disease: | Normal |
Morphology: | fibroblast |
Growth Properties: | Adherent |
Ⅳ.Representative Data | |
Figure 1.GLP1R/CRE Reporter -BHK Recombinant Cell Line (C22). |